TP53 and adrenal cortex carcinoma: TP53 mutations in ACC disrupt the p53 tumor suppressor pathway, leading to uncontrolled cell proliferation, DNA damage accumulation, and increased genomic instability; these mutations are notably common in Li-Fraumeni syndrome and sporadic ACC.